BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34229456)

  • 1. A Rare Case Report of a Corpus Callosal Splenial Lesion in the Context of Atypical Neuroleptic Malignant Syndrome.
    Serdenes R; Orr S; Trio P; Chandrasekhara S; Musselman M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211029751. PubMed ID: 34229456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.
    Kaino K; Kumagai R; Furukawa S; Isono M; Muramatsu A; Fujii M; Muta Y; Asada T; Fujihara K; Yagyu H
    J Diabetes Investig; 2017 May; 8(3):392-394. PubMed ID: 27863115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible abnormality of the splenium in a bipolar patient with neuroleptic malignant syndrome.
    Achalia R; Andrade C
    Bipolar Disord; 2014 Nov; 16(7):773-5. PubMed ID: 24330276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium induced reversible Splenial lesion in neuroleptic malignant syndrome like symptoms: two case reports.
    Ryu HU; Chung JY; Shin BS; Kang HG
    BMC Neurol; 2020 Apr; 20(1):164. PubMed ID: 32354328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Reversible Isolated Lesion in the Splenium of Corpus Callosum in a Patient with Probable Neuroleptic Malignant Syndrome -- Case Report.
    Yeh CT; Fu CH
    Acta Neurol Taiwan; 2015 Sep; 24(3)():87-91. PubMed ID: 27333832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible splenial lesion syndrome in neuroleptic malignant syndrome.
    Al-Edrus S; Norzaini R; Chua R; Puvanarajah S; Shuguna M; Muda S
    Biomed Imaging Interv J; 2009 Oct; 5(4):e24. PubMed ID: 21610992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome induced by atypical antipsychotics.
    Farver DK
    Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Neuroleptic Malignant Syndrome: Diagnosis and Proposal for an Expanded Treatment Algorithm: A Case Report.
    Schreiner NM; Windham S; Barker A
    A A Case Rep; 2017 Dec; 9(12):339-343. PubMed ID: 28767476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically mild encephalopathy with a reversible splenial lesion and nonconvulsive status epilepticus in a schizophrenic patient with neuroleptic malignant syndrome.
    Mogi T; Toda H; Tatsuzawa Y; Fukutomi T; Soga S; Shinmoto H; Yoshino A
    Psychiatry Clin Neurosci; 2017 Mar; 71(3):212. PubMed ID: 27976828
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient lesions of the splenium of the corpus callosum following rapid withdrawal of levetiracetam.
    Sawagashira R; Narita H; Hashimoto N; Kurita T; Nakagawa S; Saitoh T; Kusumi I
    Epileptic Disord; 2017 Sep; 19(3):379-382. PubMed ID: 28721933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
    Croarkin PE; Emslie GJ; Mayes TL
    J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible splenial lesion in neuroleptic malignant syndrome.
    Gasparini A; Poloni N; Caselli I; Ielmini M; Callegari C
    Panminerva Med; 2018 Sep; 60(3):134-135. PubMed ID: 29696960
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome presenting without initial fever: a case report.
    Totten VY; Hirschenstein E; Hew P
    J Emerg Med; 1994; 12(1):43-7. PubMed ID: 8163804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient Splenial Lesion of the Corpus Callosum Related to Migraine with Aura in a Pediatric Patient.
    Ünver O; Kutlubay B; Besci T; Ekinci G; Baltacıoğlu F; Türkdoğan D
    Acta Medica (Hradec Kralove); 2016; 59(2):64-6. PubMed ID: 27526308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agraphia with reversible splenial corpus callosum lesion caused by hypoglycemia.
    Miyakawa Y; Fuchigami T; Aoki M; Mine Y; Suzuki J; Urakami T; Takahashi S
    Brain Dev; 2018 Aug; 40(7):592-595. PubMed ID: 29606344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neuroleptic malignant syndrome associated with clozapine treatment.
    Amore M; Zazzeri N; Berardi D
    Neuropsychobiology; 1997; 35(4):197-9. PubMed ID: 9246221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.